Comments
Loading...
Travere Therapeutics (TVTX) Forecast
NewsEarningsTravere Therapeutics (TVTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTravere Therapeutics (NASDAQ:TVTX) Stock Quotes, Forecast and News Summary
Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Travere Therapeutics (TVTX) stock?
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Who are Travere Therapeutics (TVTX) competitors?
Other companies in Travere Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for Travere Therapeutics (TVTX) stock?
Travere Therapeutics has a consensus price target of $25.32.
What is the current price for Travere Therapeutics (TVTX)?
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $17.86 last updated November 21, 2024 at 9:24 AM EST.
Does Travere Therapeutics (TVTX) pay a dividend?
There are no upcoming dividends for Travere Therapeutics.
When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?
Travere Therapeutics’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Travere Therapeutics (TVTX) going to split?
There is no upcoming split for Travere Therapeutics.
What sector and industry does Travere Therapeutics (TVTX) operate in?
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.